COMP <GO>
FBIO vs SPRO // EV/EBITDA & P/E VALUATION
Fortress Biotech Inc. (NASDAQ) VS. Spero Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: FBIO 2
— SPRO 5
■ METRIC PARITY
LAST: $1.92 (-4.00%) • MKT CAP: $66.7M
valuation
—
LAST: $1.06 (-4.50%) • MKT CAP: $64.6M
valuation
5.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FBIO VS. SPRO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FBIO | SPRO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.90% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 26.60% | -61.60 | SPRO | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 5.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -19.53% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 50.20% | -110.20 | SPRO | /operating-margins <GO> |
| Net Profit Margin | 58.50% | 68.00% | -9.50 | SPRO | /net-margins <GO> |
| Revenue Growth (YoY) | 9.70% | 180.00% | -170.30 | SPRO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.00% | 0.00% | +1.00 | FBIO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.7 | 41.2 | -2.50 | SPRO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 6.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $66.7M | $64.6M | $2.1M | FBIO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FBIO REV | SPRO REV | FBIO GROSS % | SPRO GROSS % | FBIO FCF | SPRO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $63.3M | $12.6M | 66.9% | — | -$65.8M | -$12.6M |
| FY 2024 | $57.7M | $371.0K | 63.8% | — | -$80.2M | -$23.4M |
| FY 2023 | $84.5M | $933.0K | — | — | -$128.2M | -$33.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FBIO // BETA —
SPRO // BETA —